Market revenue in 2024 | USD 1,511.7 million |
Market revenue in 2030 | USD 3,629.6 million |
Growth rate | 15.7% (CAGR from 2024 to 2030) |
Largest segment | Powder |
Fastest growing segment | Pills |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Liquid, Powder, Softgels, Pills |
Key market players worldwide | Glanbia PLC, Abbott Laboratories, Nestle SA, The Kraft Heinz Co, PepsiCo Inc, Ajinomoto Co Inc, GSK PLC ADR, Herbalife Ltd, WK Kellogg Co, Amway Malaysia Holdings |
Powder was the largest segment with a revenue share of 37.68% in 2024. Horizon Databook has segmented the China weight loss supplements market based on liquid, powder, softgels, pills covering the revenue growth of each sub-segment from 2018 to 2030.
The competition in China weight loss supplements market is expected to be driven by several initiatives, such as partnerships, collaborations, and expansions, being undertaken by manufacturers and retailers.
Moreover, e-commerce platforms revolutionized the distribution and sales of supplements in China, providing a convenient and accessible platform for consumers and offering brand opportunities to reach a wide customer base.
Major e-commerce platforms, such as Kaola.com, Alibaba, GNC China, and Watsons Online, offer a wide range of health supplement brands in the country. Thus, the continuous growth of e-commerce in China is expected to shape the weight loss supplements market.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account